[K1] Kick-off Meeting for the MCM Program 1

2:01 PM - 2:08 PM JST(5:01 AM - 5:08 AM UTC)

[K1-04] Development of SARS-CoV-2 entry inhibitors

*Mizuki Yamamoto¹, Yoko Hirayama¹, Jun-ichiro Inoue², Yasushi Kawaguchi^3,1,2, Xuenan Xuan¹ (1. Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo (Japan), 2. The University of Tokyo Pandemic preparedness, Infection and Advanced research center (UTOPIA), The University of Tokyo (Japan), 3. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan))

Keywords:

SARS-CoV-2,membrane fusion,inhibitor,neutralizing antibody

Password required to view

Log in

or